Update on smoking cessation therapies

Advances in Therapy

Volumn 26, Issue 4, 2009, Pages 369-382

  Glynn, Deirdre A ^a   Cryan, John F ^b   Kent, Pauline ^a   Flynn, Robert A ^a   Kennedy, Marcus P ^a  

^a SLIGO UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antidepressant; Bupropion; Chronic obstructive pulmonary disease; Ischemic heart disease; Lung cancer; Nicotine; Smoking; Tobacco; Vaccination; Varenicline

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE DERIVATIVE; ANXIOLYTIC AGENT; BROMOCRIPTINE; CLONIDINE; CYTISINE; NICOTINE; NICOTINE VACCINE; NORTRIPTYLINE; OPIATE; PLACEBO; RIMONABANT; SELEGILINE; TOPIRAMATE; VARENICLINE;

ABNORMAL DREAMING; AGITATION; CIGARETTE SMOKING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; COUGHING; COUNSELING; DEPRESSION; DIAPHORESIS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG EXCRETION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG POTENCY; DRUG SAFETY; EDEMA; EDUCATION; EPIPHORA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEART PALPITATION; HUMAN; INSOMNIA; JAW DISEASE; JAW FATIGUE; LIVER DISEASE; LOW DRUG DOSE; LOZENGE; MAINTENANCE THERAPY; MENTAL DISEASE; MONOTHERAPY; MOUTH ULCER; NAUSEA; NICOTINE REPLACEMENT THERAPY; NONHUMAN; OBESITY; PSYCHOPATHY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; REVIEW; RISK REDUCTION; SEIZURE; SIDE EFFECT; SKIN IRRITATION; SLEEP DISORDER; SMOKING CESSATION; SNEEZING; SORENESS; SUICIDAL IDEATION; THROAT IRRITATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREMOR; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BENZAZEPINES; BUPROPION; COST OF ILLNESS; DRUG APPROVAL; HUMANS; MORBIDITY; NICOTINE; NICOTINIC AGONISTS; QUINOXALINES; SAFETY; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; UNITED STATES; WORLD HEALTH;

EID: 73449107507     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0022-9     Document Type: Review

References (73)

1. R.J. Mason A.S. Buist E.B. Fisher J.A. Merchant J.M. Samet C.H. Welsh 1985 Cigarette smoking and health Am Rev Respir Dis. 132 1133 1136 4062043 1:STN:280:DyaL28%2FkvVyktA%3D%3D
2. Centers for Disease Control and Prevention. Sample adult core component of the 1997-2006 National Health Interview Survey. Available at: http://www.cdc.gov/nchs/data/hus/hus08pdf#063. Accessed March 4, 2009.
3. American Thoracic Society. Cigarette smokinghealth. 1996 Am J Respir Crit Care Med. 153 861 865
4. M. Ezatti A.D. Lopez 2003 Estimates of global mortality attributable to smoking in 2000 Lancet. 362 847 852 10.1016/S0140-6736(03)14338-3 (Pubitemid 37130092)
5. Centers for Disease ControlPrevention 1999 Tobacco use - United States, 1900-1999 MMWR Morb Mortal Wkly Rep. 48 986 993
6. Centers for Disease ControlPrevention 2002 Annual smoking attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999 MMWR Morb Mortal Wkly Rep. 51 300 303
7. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun 2007 Cancer statistics, 2007 CA Cancer J Clin. 57 43 66 17237035 10.3322/canjclin.57.1.43
8. P.D. Scanlon J.E. Connett L.A. Waller M.D. Altose W.C. Bailey A.S. Buist 2000 Smoking cessation in mild to moderate chronic obstructive pulmonary disease. The Lung Health Study Am J Respir Crit Care Med. 161 381 390 10673175 1:STN:280:DC%2BD3c7otVantg%3D%3D
9. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: National Center of Chronic Disease Prevention and Health Promotion; 2004.
10. M. Ezzati S.J. Henley M.J. Thun A.D. Lopez 2005 Role of smoking in global and regional cardiovascular mortality Circulation. 112 489 497 16027251 10.1161/CIRCULATIONAHA.104.521708 (Pubitemid 41060788)
11. N.S. Godtfredsen C. Holst E. Prescott 2002 Smoking reduction, smoking cessation, and mortality: a 16 year follow up of 19,732 men and women from the Copenhagen centre for prospective population studies Am J Epidemiol. 156 994 1001 12446255 10.1093/aje/kwf150 (Pubitemid 35396928)
12. J.M. Samet 1992 The health benefits of smoking cessation Med Clin North Am. 76 399 414 1548968 1:STN:280:DyaK387psVyksQ%3D%3D
13. N.R. Anthonisen J.E. Connett J.P. Kiley 1994 Effects of smoking intervention and the use of inhaled anticholinergic bronchodilators on the rate of decline of FEV1 JAMA. 272 1497 1505 7966841 10.1001/jama.272.19.1497 1:STN:280:DyaK2M%2Fls1ejtQ%3D%3D (Pubitemid 24340791)
14. US Department of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General, 1990. DHHS Publication No. (CDC) 90-8416. Rockville, MD: US Public Health Services, Office on Smoking and Health; 1990.
15. D.H. Taylor Jr V. Hassalblad S.J. Henley M.J. Thun F.A. Sloan 2002 Benefits of smoking cessation for longevity Am J Public Health. 92 990 996 12036794 10.2105/AJPH.92.6.990
16. Tobacco UseDependence Clinical Practice Guideline Panel, Staff,Consortium Representatives. 2000 A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report JAMA. 283 3244 3254 10.1001/jama.283.24.3244
17. J.E. Anderson D.E. Jorenby W.J. Scott M.C. Fiore 2002 Treating tobacco use and dependence: an evidencebased clinical practice guideline for tobacco cessation Chest. 121 932 941 11888979 10.1378/chest.121.3.932 (Pubitemid 34251461)
18. N.A. Rigotti 2002 Treatment of tobacco use and dependence N Engl J Med. 346 506 512 11844853 10.1056/NEJMcp012279 (Pubitemid 34441743)
19. US Preventive Services Task Force. Counseling to prevent tobacco use and tobacco-caused disease: recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality; 2003.
20. Office of the US Surgeon General. The health consequences of smoking: nicotine addiction: a report of the Surgeon General. DHHS Publication No. (CDC) 88-8406. Atlanta, GA: Centers for Health Promotion and Education, Office on Smoking and Health; 1988.
21. J.E. Henningfield J.M. Stapelton N.I. Benowitz R.F. Grayson E.D. London 1993 Higher levels of nicotine in arterial than in venous blood after cigarette smoking Drug Alcohol Depend. 33 23 29 8370337 10.1016/0376-8716(93)90030-T 1:CAS:528:DyaK2cXht1OmtLo%3D
22. S.S. Watkins G.F. Koob A. Markou 2000 Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal Nicotine Tob Res. 2 19 37 11072438 10.1080/14622200050011277 1:CAS:528:DC%2BD3cXnslensLc%3D
23. J.R. Hughes 2007 Effects of abstinence from tobacco: valid symptoms and time course Nicotine Tob Res. 9 315 327 17365764 10.1080/14622200701188919 (Pubitemid 46404264)
24. Fiore MC, Jaen CR, Baker TB, et al. Clinical practice guideline: treating tobacco use and dependence 2008 update. Rockville, MD: Department of Health and Human Services; 2008.
25. K.S. Okuyeni J.S. Ahluwalia K.J. Harris 2000 Pharmacotherapy of smoking cessation Arch Fam Med. 9 270 281 10.1001/archfami.9.3.270
26. A. Molyneux 2004 Nicotine replacement therapy BMJ. 328 454 456 14976103 10.1136/bmj.328.7437.454
27. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000146.
28. W. Lam P.C. Sze H.S. Sacks T.C. Chalmers 1987 Metaanalysis of randomised controlled trials of nicotine chewing-gum Lancet. 2 27 30 2885512 10.1016/S0140-6736(87)93061-3 1:STN:280:DyaL2s3ls1CgtA%3D%3D
29. N.G. Schneider E. Lunell R.E. Olmstead K.O. Fagerström 1996 Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems Clin Pharmacokinet. 31 65 80 8827400 10.2165/00003088- 199631010-00005 1:CAS:528:DyaK28XltVWqu7s%3D
30. M.C. Fiore S.S. Smith D.E. Jorenby T.B. Baker 1994 The effectiveness of the nicotine patch for smoking cessation. A meta-analysis JAMA. 271 1940 1947 8201739 10.1001/jama.271.24.1940 1:STN:280:DyaK2c3mtVKkug%3D%3D (Pubitemid 24177103)
31. N.G. Schneider R. Olmstead F.V. Mody, et al. 1995 Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial Addiction. 90 1671 1682 8555958 10.1111/j.1360-0443.1995.tb02837.x 1:STN:280:DyaK287islKlsg%3D%3D
32. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;(1):CD000146.
33. R. Hajek R. West J. Foulds F. Nilsson S. Burrows A. Meadow 2000 Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler Arch Intern Med. 159 2033 2038 10.1001/archinte.159.17. 2033
34. A. Bohadana F. Nilsson T. Rasmussen Y. Martinet 2000 Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo controlled trial Arch Intern Med. 160 3128 3134 11074742 10.1001/archinte.160.20.3128 1:CAS:528:DC%2BD3cXosFSgsbc%3D
35. N.L. Benowitz G.G. Steven 1997 Cardiovascular toxicity of nicotine: implication for nicotine replacement therapy J Am Coll Cardiol. 7 1422 1437 10.1016/S0735-1097(97)00079-X (Pubitemid 27272432)
36. D.A. Dempsey N.L. Benowitz 2001 Risks and benefits of nicotine to aid smoking cessation in pregnancy Drug Saf. 24 277 322 11330657 10.2165/00002018-200124040-00005 1:CAS:528:DC%2BD3MXjs12jurc%3D
37. T. Coleman J. Britton J. Thornton 2004 Nicotine replacement therapy in pregnancy BMJ. 328 965 966 15105300 10.1136/bmj.328.7446.965
38. J.E. Rose 2006 Nicotine and nonnicotine factors in cigarette addiction Psychopharmacology (Berl). 184 274 285 10.1007/s00213-005-0250-x 1:CAS:528:DC%2BD28XhsFCltrs%3D (Pubitemid 43255844)
39. D.J. Balfour 2001 The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion Int J Clin Pract. 55 53 57 11219320 1:CAS:528:DC%2BD3MXhs1Wiu7Y%3D
40. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007;(1):CD000031.
41. J.A. Ascher J.O. Cole J.N. Colin 1995 Bupropion: a review of its mechanism of antidepressant activity J Clin Psychiatry. 56 395 401 7665537 1:STN:280:DyaK2MzpsVyksw%3D%3D
42. J.F. Cryan A. Dalvi S.H. Jin B.R. Hirsch I. Lucki S.A. Thomas 2001 Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs J Pharmacol Exp Ther. 298 651 657 11454927 1:CAS:528:DC%2BD3MXlsVKqsbo%3D
43. J.H. Meyer V.S. Goulding A.A. Wilson D. Hussey B.K. Christensen S. Houle 2002 Bupropion occupancy of the dopamine transporter is low during clinical treatment Psychopharmacology. 163 102 105 12185406 10.1007/s00213-002-1166-3 1:CAS:528:DC%2BD38XosVGrtbc%3D (Pubitemid 34985318)
44. J.E. Semmer B.R. Martin M.I. Damaj 2000 Bupropion is a nicotinic antagonist J Pharmacol Exp Ther. 295 321 327
45. R.D. Hurt D.P.L. Sachs E.D. Glover 1997 A comparison of slow release buproprion and placebo for smoking cessation N Engl J Med. 337 1195 1202 9337378 10.1056/NEJM199710233371703 1:CAS:528:DyaK2sXntVaqsLc%3D (Pubitemid 27454451)
46. G.E. Swan T. McAfee S.J. Curry 2003 Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial Arch Intern Med. 163 2337 2344 14581254 10.1001/archinte.163.19.2337 1:CAS:528:DC%2BD3sXptlCnsr8%3D (Pubitemid 37310195)
47. D.E. Jorenby S.J. Leischow M.A. Nides 1999 A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med. 340 685 691 10053177 10.1056/NEJM199903043400903 1:CAS:528:DyaK1MXhvFWhsLk%3D (Pubitemid 29110752)
48. Fiore MC, Bailey WC, Cohen SJ et al. Treating tobacco use and dependence. Rockville, MD: Department of Health and Human Services, Public Health Service; 2000.
49. S. Wilkes 2008 The use of bupropion SR in cigarette smoking cessation Int J Chron Ostruct Pulmon Dis. 3 45 53 1:CAS:528:DC%2BD1cXltl2ns74%3D
50. Y.E. Slater L.M. Houlihan P.D. Maskell 2003 Halogenated cytosine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes Neuropharmacology. 44 503 515 12646287 10.1016/S0028-3908(03)00025-X 1:CAS:528:DC%2BD3sXhvFSltr8%3D (Pubitemid 36293982)
51. J.W. Coe P.R. Brooks M.G. Vetelino 2005 Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation J Med Chem. 48 3474 3477 15887955 10.1021/jm050069n 1:CAS:528:DC%2BD2MXjsFyjtb4%3D (Pubitemid 40664098)
52. P. Aveyard R. West 2007 Managing smoking cessation BMJ. 335 37 41 17615224 10.1136/bmj.39252.591806.47 (Pubitemid 47066906)
53. D.E. Jorenby J.T. Hays N.A. Rigotti, et al. 2006 Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial JAMA. 296 56 63 16820547 10.1001/jama.296.1.56 1:CAS:528:DC%2BD28Xms1OrtL0%3D
54. S. Tonstad P. Tonnensen P. Hajek K.E. Williams C.B. Billing K.R. Reeves 2006 Varenicline Phase 3 Study Group. Effects of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial JAMA. 296 64 71 16820548 10.1001/jama.296.1.64 1:CAS:528:DC%2BD28Xms1OrtLo%3D
55. D. Gonzales S.I. Rennard M. Nides 2006 Varenicline Phase 3 Study Group. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist vs sustained release bupropion and placebo for smoking cessation: a randomized controlled trial JAMA. 296 47 55 16820546 10.1001/jama.296.1.47 1:CAS:528:DC%2BD28Xms1OrtLw%3D
56. M.J. Eisenberg K.B. Filion D. Yavin 2008 Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials CMAJ. 179 135 144 18625984
57. J.A. Stapleton L. Watson L.I. Spirling 2008 Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness Addiction. 103 146 154 18028247 10.1111/j.1360-0443.2007.02083.x (Pubitemid 350233424)
58. H.J. Aubin A. Bobak J.R. Britton 2008 Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial Thorax. 63 717 724 18263663 10.1136/thx.2007.090647
59. J.T. Hays J.O. Ebbert 2008 Varenicline for tobacco dependence N Engl J Med. 359 2018 2024 18987369 10.1056/NEJMct0800146 1:CAS:528:DC%2BD1cXhtleisrvO
60. US Drug and Food Administration, Center for Drug Evaluation and Research. Varenicline [marketed as Chantix] information. Washington, DC: US Department of Health and Human Services; 2008.
61. R.S. Obach A.E. Reed-Hagen S.S. Krueger 2006 Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro Drug Metab Dispos. 34 121 130 16221753 10.1124/dmd.105. 006767 1:CAS:528:DC%2BD28Xhslyjuw%3D%3D (Pubitemid 43042653)
62. J.F. Etter 2006 Cytisine for smoking cessation: a literature review and a meta-analysis Arch Intern Med. 166 1553 1559 16908787 10.1001/archinte.166.15. 1553 1:CAS:528:DC%2BD28XpsFGntr8%3D (Pubitemid 44232362)
63. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2004;(3):CD000058.
64. B.A. Johnson N. Ait-Daoud F.Z. Akhtar M.A. Javors 2005 Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial Arch Intern Med. 165 1600 1605 16043677 10.1001/archinte.165.14.1600 1:CAS:528:DC%2BD2MXos1Cntrw%3D (Pubitemid 41124153)
65. T.P. George J.C. Vessicchio A. Termine P.I. Jatlow T.R. Kosten S.S. O'Malley 2003 A preliminary placebocontrolled trial of selegiline hydrochloride for smoking cessation Biol Psychiatry. 53 136 143 12547469 10.1016/S0006- 3223(02)01454-3 1:CAS:528:DC%2BD3sXltlWksQ%3D%3D (Pubitemid 36126476)
66. M.E. Jarvik N.H. Caskey W.C. Wirshing 2000 Bromocriptine reduces cigarette smoking Addiction. 95 1173 1183 11092065 10.1046/j.1360-0443.2000. 95811734.x 1:STN:280:DC%2BD3M%2FltFCksQ%3D%3D (Pubitemid 30644103)
67. Cahill K, Ussher M. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database Syst Rev. 2007;(4):CD005353.
68. J.F. Cryan F. Gasparini G. van Heeke A. Markou 2003 Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion Drug Discov Today. 8 1025 1034 14690633 10.1016/S1359-6446(03)02890-3 1:CAS:528:DC%2BD3sXpvVOmsLs%3D (Pubitemid 38018809)
69. J. Cornuz S. Zwahlen W.F. Jungi 2008 A vaccine against nicotine for smoking cessation: a randomized controlled trial PLoS ONE. 3 e2547 18575629 10.1371/journal.pone.0002547
70. M. Law J.L. Tang 1995 An analysis of the effectiveness of interventions intended to help people stop smoking Arch Intern Med. 155 1933 1941 7575046 10.1001/archinte.155.18.1933 1:STN:280:DyaK28%2Fgs1Wgsw%3D%3D
71. N.A. Rigotti M.R. Munafo L.F. Stead 2008 Smoking cessation interventions for hospitalized smokers: a systematic review Arch Intern Med. 168 1950 1960 18852395 10.1001/archinte.168.18.1950
72. G. Stratelis S. Mölstad P. Jakobsson O. Zetterström 2006 The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD Scand J Prim Health Care. 24 133 139 16923621 10.1080/02813430600819751 (Pubitemid 44272848)
73. R. Doll R. Peto J. Boreham I. Sutherland 2004 Mortality in relation to smoking: 50 years observation on male British doctors BMJ. 328 1519 15213107 10.1136/bmj.38142.554479.AE